We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Magnetic Particle Processing Attracts Influenza Researchers

By LabMedica International staff writers
Posted on 07 Nov 2011
Print article
A German life sciences research laboratory has acquired an advanced magnetic particle processor to enhance its efforts to study the molecular genetics of the H1N1 influenza virus that was responsible for last year’s flu pandemic.

The University of Applied Sciences (Bielefeld, Germany) will now be employing a new Thermo Fisher Scientific Inc. (Milford, MA, USA) KingFisher Flex magnetic particle processor. The instrument’s patented magnetic separation technology is expected to streamline high-throughput data collection.

The KingFisher Flex has been described as a truly flexible solution for genomics studies with a 24-rod magnetic head in combination with a 24-well deep plate. This format allows users to achieve processing volumes up to five mL. Alternatively, for higher throughput requirements, 96 samples can be processed from 20 mL-1,000 mL total volume using a 96-rod magnetic head and 96-well deep or shallow plates.

The KingFisher is an open and flexible system that lets the operator use any magnetic particle based kit to meet the application demands while its easy-to-use BindIt Software package provides instrument control, protocol creation, and modification capabilities.

“As viral strains increasingly mutate, they become harder for the adaptive immune system to fight, and, therefore, they pose a significant health threat to the general public,” said Dr. Carsten Tiemann, project director at the University of Applied Sciences. “In our work within infectious diseases, specifically H1N1 screening, we found the KingFisher Flex to be extremely fast and reliable for nucleic acid extraction for subsequent downstream analysis.”

Related Links:
University of Applied Sciences
Thermo Fisher Scientific Inc.

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
TETANUS Test
TETANUS VIRCLIA IgG MONOTEST
New
Gold Member
Hepatitis C Virus Test
HCV - I521

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.